{"url_path":"/sec/tara/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1359931/0001213900-26-055463-index.html","accession_number":"0001213900-26-055463","cik":"0001359931","ticker":"TARA","issuer_name":"Protara Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1359931/0001213900-26-055463-index.html","primary_entity_key":"0001359931","primary_entity_name":"Protara Therapeutics, Inc."},"word_count":44,"has_tables":true,"body_markdown":"**Item 1A. Risk Factors**\n\n** **\n\nThere\nwere no material changes to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors” of our Annual Report\non Form 10-K for the year ended December 31, 2025, filed with the SEC on March 10, 2026."}